Immunic Cash from Financing (TTM) Insights

Immunic Inc (IMUX)

1.395 +0.04 (+2.57%) USD | NASDAQ | May 07, 16:00

1.395 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	1.033M
September 30, 2023	56.47M
June 30, 2023	56.19M
March 31, 2023	66.17M
December 31, 2022	95.76M
September 30, 2022	40.54M
June 30, 2022	82.56M
March 31, 2022	72.48M
December 31, 2021	42.84M
September 30, 2021	50.13M
June 30, 2021	104.65M
March 31, 2021	143.86M
December 31, 2020	144.43M
September 30, 2020	141.03M
June 30, 2020	44.71M
March 31, 2020	14.93M
December 31, 2019	34.90M
September 30, 2019	30.19M
June 30, 2019	29.99M
March 31, 2019	20.56M
December 31, 2018	0.004M

Date	Value
September 30, 2018	0.544M
June 30, 2018	0.34M
March 31, 2018	0.128M
December 31, 2017	37.98M
September 30, 2017	38.55M
June 30, 2017	41.16M
March 31, 2017	45.87M
December 31, 2016	12.37M
September 30, 2016	43.73M
June 30, 2016	41.12M
March 31, 2016	36.61M
December 31, 2015	32.42M
September 30, 2015	33.68M
June 30, 2015	33.84M
March 31, 2015	88.98M
December 31, 2014	106.92M
September 30, 2014	90.88M
June 30, 2014	89.44M
March 31, 2014	66.21M
December 31, 2013	50.44M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.033M

Minimum

Dec 2023

144.43M

Maximum

Dec 2020

65.94M

Average

56.19M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks